Re: “Monopolar vs. bipolar transurethral resection for nonmuscle invasive bladder carcinoma: A post hoc analysis from a randomized controlled trial”

The authors have published a valuable article that compares safety and efficacy between monopolar transurethral resection of bladder (mTURB) and bipolar (bTURB) for patients with primary nonmuscle invasive bladder cancer. They have found no evident advantages of bTURB over mTURB with respect to operation time, perioperative and postoperative complication rates, and recurrence rates at 12 months [1]. The mainstay for the diagnosis and initial treatment of bladder cancer is TURBT, aiming at reaching a definitive diagnosis and removing all visible lesions including a part of underlying muscle [2].
Source: Urologic Oncology: Seminars and Original Investigations - Category: Urology & Nephrology Authors: Tags: Letter to the Editor Source Type: research